Lymphoma Trial, Recruiting (NCT07479927)

Lymphoma Trial, Recruiting NCT07479927 Sponsor: Hospital Universitario La Paz Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT07479927 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with acute B-cell lymphoblastic leukemia (a type of blood cancer).
People who have previously received at least one of the following treatments: CAR-T cell therapy, chemotherapy, or a stem cell transplant.
People between the ages of 8 and 18 years old.
People who are native Spanish speakers or who speak Spanish at a high enough level to understand the study procedures and complete the study questionnaires.
People who have access to a computer, tablet, or smartphone with an internet connection.

Who may not be able to join:

People who have a diagnosis of an intellectual disability, autism spectrum disorder, or an acquired brain injury (such as from an accident or illness affecting the brain).
People who have a medical or mental health condition — unrelated to leukemia — that is currently unstable or not well managed.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34917277417

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07479927

Sponsor: Hospital Universitario La Paz

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

Trial contact: +34917277417

More information: https://clinicaltrials.gov/study/NCT07479927

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with acute B-cell lymphoblastic leukemia (a type of blood cancer).
People who have previously received at least one of the following treatments: CAR-T cell therapy, chemotherapy, or a stem cell transplant.
People between the ages of 8 and 18 years old.
People who are native Spanish speakers or who speak Spanish at a high enough level to understand the study procedures and complete the study questionnaires.
People who have access to a computer, tablet, or smartphone with an internet connection.

Who may not be able to join:

People who have a diagnosis of an intellectual disability, autism spectrum disorder, or an acquired brain injury (such as from an accident or illness affecting the brain).
People who have a medical or mental health condition — unrelated to leukemia — that is currently unstable or not well managed.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hospital Universitario La Paz

Registry

ClinicalTrials.gov

Start date

19 December 2025

Est. completion

30 July 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Symbol Digit Modalities Test (SDMT).; Continuous Performance Test, third edition (CPT-3); Clinical Assessment of Memory (ECM); Verbal Fluency Test (VFT); Stroop. Test of Colors and Words. Revised edition.; Symbol Digit Modalities Test (SDMT); Continuous Performance Test, third edition (CPT-3); Clinical Assessment of Memory (ECM); Stroop. Test of Colors and Words. Revised edition; Verbal Fluency Test (VFT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov